Andrea Moore

1.4k total citations · 1 hit paper
11 papers, 931 citations indexed

About

Andrea Moore is a scholar working on Pulmonary and Respiratory Medicine, Radiation and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Andrea Moore has authored 11 papers receiving a total of 931 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Pulmonary and Respiratory Medicine, 6 papers in Radiation and 3 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Andrea Moore's work include Advanced Radiotherapy Techniques (6 papers), Prostate Cancer Diagnosis and Treatment (5 papers) and Prostate Cancer Treatment and Research (4 papers). Andrea Moore is often cited by papers focused on Advanced Radiotherapy Techniques (6 papers), Prostate Cancer Diagnosis and Treatment (5 papers) and Prostate Cancer Treatment and Research (4 papers). Andrea Moore collaborates with scholars based in United Kingdom, United States and Australia. Andrea Moore's co-authors include David P. Dearnaley, Edwin Aird, Matthew R. Sydes, Rachel C. Morgan, Isabel Syndikus, Richard Stephens, John M. Russell, Christopher Scrase, Mahesh Parmar and John D. Graham and has published in prestigious journals such as Journal of Clinical Oncology, The Lancet Oncology and International Journal of Radiation Oncology*Biology*Physics.

In The Last Decade

Andrea Moore

11 papers receiving 917 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Escalated-dose versus standard-dose conformal radiotherapy in prostate cancer: first results from the MRC RT01 randomised controlled trial

2007 686 citations David P. Dearnaley, Matthew R. Sydes et al. The Lancet Oncology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Andrea Moore United Kingdom	7	832	595	193	93	83	11	931
Chakiath Jose New Zealand	7	1.1k 1.3×	765 1.3×	188 1.0×	144 1.5×	69 0.8×	9	1.2k
André‐Guy Martin Canada	19	774 0.9×	504 0.8×	176 0.9×	148 1.6×	144 1.7×	90	1.0k
Larry B. Levy United States	12	1.0k 1.2×	441 0.7×	112 0.6×	176 1.9×	90 1.1×	15	1.2k
Andrea Deabreu Canada	19	1.0k 1.2×	801 1.3×	160 0.8×	94 1.0×	38 0.5×	62	1.1k
Margaret Bidmead United Kingdom	13	490 0.6×	523 0.9×	300 1.6×	103 1.1×	44 0.5×	26	727
Hima Bindu Musunuru Canada	15	683 0.8×	356 0.6×	153 0.8×	168 1.8×	85 1.0×	55	823
Michel F.H. Dielwart Netherlands	5	1.2k 1.5×	942 1.6×	293 1.5×	133 1.4×	88 1.1×	7	1.4k
C Marion United States	5	660 0.8×	560 0.9×	219 1.1×	108 1.2×	36 0.4×	7	798
M. Seke Sweden	6	622 0.7×	438 0.7×	184 1.0×	75 0.8×	73 0.9×	6	737
Peter-Paul van der Toorn Netherlands	8	457 0.5×	368 0.6×	166 0.9×	70 0.8×	61 0.7×	14	634

Countries citing papers authored by Andrea Moore

Since Specialization

Citations

This map shows the geographic impact of Andrea Moore's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andrea Moore with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andrea Moore more than expected).

Fields of papers citing papers by Andrea Moore

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Andrea Moore. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andrea Moore. The network helps show where Andrea Moore may publish in the future.

Co-authorship network of co-authors of Andrea Moore

This figure shows the co-authorship network connecting the top 25 collaborators of Andrea Moore. A scholar is included among the top collaborators of Andrea Moore based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Andrea Moore. Andrea Moore is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

11 of 11 papers shown

Barrett, David M., Karen Chagin, Thomas J. Fountaine, et al.. (2022). TmPSMA-02: A CD2 endodomain containing double armored PSMA CAR T with enhanced efficacy and lower immune toxicity.. Journal of Clinical Oncology. 40(6_suppl). 158–158. 4 indexed citations

Smyth, G., Philip Evans, Jeffrey C. Bamber, et al.. (2019). Dosimetric accuracy of dynamic couch rotation during volumetric modulated arc therapy (DCR-VMAT) for primary brain tumours. Physics in Medicine and Biology. 64(8). 08NT01–08NT01. 11 indexed citations

Gulliford, S., Kerwyn Foo, Rachel C. Morgan, et al.. (2009). Dose–Volume Constraints to Reduce Rectal Side Effects From Prostate Radiotherapy: Evidence From MRC RT01 Trial ISRCTN 47772397. International Journal of Radiation Oncology*Biology*Physics. 76(3). 747–754. 109 indexed citations

Moore, Andrea, et al.. (2008). Extrapulmonary Tuberculosis in Pregnancy Masquerading as a Degenerating Leiomyoma. Obstetrics and Gynecology. 111(2). 550–552. 4 indexed citations

Griffiths, Stephen D., et al.. (2008). Accuracy and Reproducibility of Conformal Radiotherapy using Data from a Randomised Controlled Trial of Conformal Radiotherapy in Prostate Cancer (MRC RT01, ISRCTN47772397). Clinical Oncology. 20(8). 582–590. 9 indexed citations

Dearnaley, David P., Matthew R. Sydes, John D. Graham, et al.. (2007). Escalated-dose versus standard-dose conformal radiotherapy in prostate cancer: first results from the MRC RT01 randomised controlled trial. The Lancet Oncology. 8(6). 475–487. 686 indexed citations breakdown →

Naismith, Olivia, Catharine H. Clark, Helen Mayles, et al.. (2007). 28 Quality Assurance of Dosimetry in Centres participating in the CHHIP Prostate Radiotherapy Trial. Clinical Oncology. 19(3). S14–S14. 2 indexed citations

Moore, Andrea, A.P. Warrington, Edwin Aird, A.M. Bidmead, & David P. Dearnaley. (2006). A versatile phantom for quality assurance in the UK Medical Research Council (MRC) RT01 trial (ISRCTN47772397) in conformal radiotherapy for prostate cancer. Radiotherapy and Oncology. 80(1). 82–85. 10 indexed citations

Mayles, W. P. M., Andrea Moore, Edwin Aird, et al.. (2004). Questionnaire based quality assurance for the RT01 trial of dose escalation in conformal radiotherapy for prostate cancer (ISRCTN 47772397). Radiotherapy and Oncology. 73(2). 199–207. 17 indexed citations

10.

Tucker, Gregory A., et al.. (2001). A Cost Analysis of Four Benefit Strategies for Managing a Cox II Inhibitor. Journal of Managed Care Pharmacy. 7(3). 224–227. 3 indexed citations

11.

Sartor, Oliver, et al.. (1998). Effect of prednisone on prostate-specific antigen in patients with hormone-refractory prostate cancer. Urology. 52(2). 252–256. 76 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact